Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes

Retinal neurodegeneration is an early event in the pathogenesis of diabetic retinopathy (DR). Somatostatin (SST) is an endogenous neuroprotective peptide that is downregulated in the diabetic eye. The aim of the study was to test the usefulness of topical administration of SST in preventing retinal neurodegeneration. For this purpose, rats with streptozotocin-induced diabetes mellitus (STZ-DM) were treated with either SST eye drops or vehicle for 15 days. Nondiabetic rats treated with vehicle served as a control group. Functional abnormalities were assessed by electroretinography (ERG), and neurodegeneration was assessed by measuring glial activation and the apoptotic rate. In addition, proapoptotic (FasL, Bid, and activation of caspase-8 and caspase-3) and survival signaling pathways (BclxL) were examined. Intraretinal concentrations of glutamate and its main transporter glutamate/aspartate transporter (GLAST) were also determined. Treatment with SST eye drops prevented ERG abnormalities, glial activation, apoptosis, and the misbalance between proapoptotic and survival signaling detected in STZ-DM rats. In addition, SST eye drops inhibited glutamate accumulation in the retina and GLAST downregulation induced by diabetes mellitus. We conclude that topical administration of SST has a potent effect in preventing retinal neurodegeneration induced by diabetes mellitus. In addition, our findings open up a new preventive pharmacological strategy targeted to early stages of DR.

• Publication year

  2013

• Venue

  Diabetes

• Publication date

  2013-06-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/db12-0926PMID 23474487PMCID 3712066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy

  2013cited by this paper
• Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications

  2012cited by this paper
• Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin

  2012cited by this paper
• Diabetic retinopathy.

  2012cited by this paper
• Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals

  2012cited by this paper
• Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

  2012cited by this paper
• Mechanisms underlying somatostatin receptor 2 down‐regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants

  2012cited by this paper
• The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.

  2011cited by this paper
• Diabetic retinopathy

  2010cited by this paper
• Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage

  2010cited by this paper
• Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE)

  2010cited by this paper
• New Techniques for Drug Delivery to the Posterior Eye Segment

  2010cited by this paper
• Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity.

  2010cited by this paper
• Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy

  2009cited by this paper
• Diabetes changes the levels of ionotropic glutamate receptors in the rat retina

  2009influential reference
• Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

  2009cited by this paper
• Diabetic Retinal Neurodegeneration Is Associated With Mitochondrial Oxidative Stress and Is Improved by an Angiotensin Receptor Blocker in a Model Combining Hypertension and Diabetes

  2009cited by this paper
• Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review.

  2009cited by this paper
• AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen‐induced retinopathy

  2008cited by this paper
• Targeting intraocular neovascularization and edema--one drop at a time.

  2008cited by this paper
• Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation

  2008cited by this paper
• Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.

  2008cited by this paper
• Physiology and pathology of somatostatin in the mammalian retina: a current view.

  2008cited by this paper
• Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina

  2008cited by this paper
• Glial and endothelial blood-retinal barrier responses to amyloid-β in the neural retina of the rat

  2008cited by this paper
• Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

  2007cited by this paper
• A Role for Excitatory Amino Acids in Diabetic Eye Disease

  2007cited by this paper
• Angiotensin and diabetic retinopathy.

  2006cited by this paper
• Diabetic Retinopathy

  2006cited by this paper
• Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

  2006cited by this paper
• Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects.

  2005influential reference
• Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats.

  2004cited by this paper
• Standard for clinical electroretinography (2004 update)

  2004influential reference
• A new view of diabetic retinopathy: a neurodegenerative disease of the eye.

  2003cited by this paper
• A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.

  2003cited by this paper
• Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.

  2002influential reference
• The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology

  2001cited by this paper
• Retinal glutamate in diabetes and effect of antioxidants.

  2001cited by this paper
• [Diabetic retinopathy].

  2001cited by this paper
• Early cellular and molecular changes induced by diabetes in the retina

  2001cited by this paper
• Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy.

  2001cited by this paper
• Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group.

  2000cited by this paper
• Müller cell changes in human diabetic retinopathy.

  1998cited by this paper
• Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group.

  1998cited by this paper
• Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

  1998cited by this paper
• Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

  1997cited by this paper
• Elevated γ-Aminobutyric Acid, Glutamate, and Vascular Endothelial Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy

  1997cited by this paper
• Differential expression of three glutamate transporter subtypes in the rat retina

  1996cited by this paper
• A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy.

  1992cited by this paper

• Study of the efficacy and the mechanism of action of lanreotide for the treatment of persistent diabetic macular edema

  2025cites this paper
• Translational Research and Therapies for Neuroprotection and Regeneration of the Optic Nerve and Retina: A Narrative Review

  2024cites this paper
• Ultrasmall copper nanodots eye drops for microenvironment regulation of diabetes retinopathy by relieving hypoxia and inhibiting HIF-1α/VEGF signaling pathway

  2024cites this paper
• Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data

  2024cites this paper
• Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina

  2024cites this paper
• Compound Danshen dripping pills prevent early diabetic retinopathy: roles of vascular protection and neuroprotection

  2024cites this paper
• Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and therapeutic implications for vascular complications

  2024cites this paper
• Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy.

  2023cites this paper
• Repeated Topical Administration of 3 nm Cerium Oxide Nanoparticles Reverts Disease Atrophic Phenotype and Arrests Neovascular Degeneration in AMD Mouse Models.

  2023cites this paper
• Ocular immune privilege and retinal pigment epithelial cells.

  2023cites this paper
• On implications of somatostatin in diabetic retinopathy

  2023cites this paper
• Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina

  2023cites this paper
• Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway

  2023cites this paper
• The retina-brain axis and diabetic retinopathy

  2023cites this paper
• Three Major Causes of Metabolic Retinal Degenerations and Three Ways to Avoid Them

  2023cites this paper
• Visual Dysfunction in Diabetes

  2023cites this paper
• Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• Neuroinflammation and neurodegeneration in diabetic retinopathy

  2022cites this paper
• New Insights into Treating Early and Advanced Stage Diabetic Retinopathy

  2022cites this paper
• Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy

  2022cites this paper
• Diabetic Retinopathy: Role of Neurodegeneration and Therapeutic Perspectives.

  2022cites this paper
• Structure–Function Relationships in the Rodent Streptozotocin-Induced Model for Diabetic Retinopathy: A Systematic Review

  2022cites this paper
• Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model

  2022cites this paper
• Understanding Neurodegeneration from a Clinical and Therapeutic Perspective in Early Diabetic Retinopathy

  2022cites this paper
• In Vivo Capillary Structure and Blood Cell Flux in the Normal and Diabetic Mouse Eye

  2022cites this paper
• Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice

  2022cites this paper
• Recent trends in drug-delivery systems for the treatment of Diabetic Retinopathy and associated Fibrosis.

  2021cites this paper
• PACAP for Retinal Health: Model for Cellular Aging and Rescue

  2021cites this paper
• Early Neural Changes as Underlying Pathophysiological Mechanism in Diabetic Retinopathy

  2021cites this paper
• Liraglutide Treatment Does Not Induce Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Diabetic Retinopathy

  2021cites this paper
• Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies

  2021cites this paper
• Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy

  2021influential citation
• The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina

  2021cites this paper
• Protective Effect of Raf-1 Kinase Inhibitory Protein on Diabetic Retinal Neurodegeneration through P38-MAPK Pathway

  2021cites this paper
• Understanding intrinsic survival and regenerative pathways through in vivo and in vitro studies: implications for optic nerve regeneration

  2021cites this paper
• Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy

  2021cites this paper
• Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets

  2021cites this paper
• The effects of early diabetes on inner retinal neurons

  2020cites this paper
• Genotypic variability in radial resistance to water flow in olive roots and its response to temperature variations.

  2020cites this paper
• Recent Developments in Diabetic Retinal Neurodegeneration: A Literature Review

  2020cites this paper
• Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

  2020cites this paper
• Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.

  2020cites this paper
• Neuropathic damage in the diabetic eye: clinical implications.

  2020cites this paper
• Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes

  2020cites this paper
• Molecular and Cellular Mechanisms Underlying Somatostatin-Based Signaling in Two Model Neural Networks, the Retina and the Hippocampus

  2019cites this paper
• A non-invasive, multi-target approach to treat diabetic retinopathy.

  2019cites this paper
• Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease

  2019cites this paper
• Diabetic Retinopathy in Youth-Onset Type 2 Diabetes Mellitus

  2019cites this paper
• Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration

  2019cites this paper
• Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.

  2019cites this paper
• MiR-29 regulates retinopathy in diabetic mice via the AMPK signaling pathway.

  2019cites this paper
• Spermine oxidase: A Promising Therapeutic Target for Neurodegeneration in Diabetic Retinopathy.

  2019cites this paper
• SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes

  2019cites this paper
• Neuroprotective Peptides in Retinal Disease

  2019cites this paper
• Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina

  2019cites this paper
• Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin

  2019cites this paper
• Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy

  2019cites this paper
• Ocular delivery of proteins and peptides: Challenges and novel formulation approaches☆

  2018cites this paper
• Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration

  2018cites this paper
• Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

  2018cites this paper
• Extended-release formulations of somatostatin for ocular application and their effect on vascular endothelial growth factor as a biomarker of diabetic retinopathy

  2018cites this paper
• Impact of type 1 diabetes mellitus and sitagliptin treatment on the neuropeptide Y system of rat retina

  2018cites this paper
• Neurodegeneration in diabetic retinopathy: does it really matter?

  2018cites this paper
• Title: Functional and Structural Findings in Early Stages of Diabetic Retinopathy. Cross- sectional analyses of the baseline data of the EUROCONDOR project. Short running title: Cross-sectional analyses of the baseline results of the EUROCONDOR project

  2018cites this paper
• Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets

  2018cites this paper
• Two-photon imaging of the mammalian retina with ultrafast pulsing laser.

  2018cites this paper
• Somatostatin and diabetic retinopathy: an evolving story

  2018cites this paper
• Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy. Cross-sectional Analyses of Baseline Data of the EUROCONDOR project

  2018cites this paper
• Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy

  2018cites this paper
• The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study

  2018cites this paper
• Release kinetics of somatostatin from self‐assembled nanostructured hydrogels

  2018cites this paper
• Retina Histologic Characterization of Retina Neuroglia Modifications in Diabetic Zucker Diabetic Fatty Rats

  2017cites this paper
• Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

  2017cites this paper
• Protective treatments and their target retinal ganglion cells in diabetic retinopathy.

  2017cites this paper
• Neuroprotective effects of a novel peptide, FK18, under oxygen‐glucose deprivation in SH‐SY5Y cells and retinal ischemia in rats via the Akt pathway

  2017cites this paper
• Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project

  2017cites this paper
• Somatostatin protects human retinal pericytes from inflammation mediated by microglia

  2017cites this paper
• Caspases in retinal ganglion cell death and axon regeneration

  2017cites this paper
• Diabetic retinopathy is a neurodegenerative disorder

  2017cites this paper
• Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3

  2017cites this paper
• The Synthetic Microneurotrophin BNN27 Affects Retinal Function in Rats With Streptozotocin-Induced Diabetes

  2017cites this paper
• Title : Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy . Cross-sectional analyses of Baseline Data of the EUROCONDOR project . Short running title : EUROCONDOR Baseline Analysis

  2017cites this paper
• Histologic Characterization of Retina Neuroglia Modifications in Diabetic Zucker Diabetic Fatty Rats.

  2017cites this paper
• Retinal pigment epithelium-secretome: A diabetic retinopathy perspective.

  2017cites this paper
• Neuroprotective effects of octreotide on diabetic neuropathy in rats.

  2017cites this paper
• Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes

  2017cites this paper
• Anti‐inflammatory and retinal protective effects of capsaicin on ischaemia‐induced injuries through the release of endogenous somatostatin

  2017cites this paper
• Occludin downregulation in high glucose is regulated by SSTR2 via the VEGF/NRP1/Akt signaling pathway in RF/6A cells.

  2017cites this paper
• Anti-inflammatory and retinal protective effects of capsaicin on ischemia-induced injuries through the release of endogenous somatostatin ( Running title : Capsaicin protects the retina against ischemia injury )

  2017cites this paper
• Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy

  2017cites this paper
• Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms

  2017cites this paper
• Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy

  2016cites this paper
• Neurodegeneration as an early event in the pathogenesis of diabetic retinopathy: therapeutic implications /

  2016cites this paper
• Fracción activa del factor derivado del epitelio pigmentario (PEDF) en el tratamiento de la neovascularización coroidea en modelo animal de degeneración macular asociada a la edad

  2016cites this paper
• 2 . Neurodegeneration in DR and the Role of VEGF

  2016cites this paper
• VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.

  2016cites this paper
• Somatostatin protects photoreceptor cells against high glucose – induced apoptosis

  2016influential citation
• rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus

  2016influential citation
• Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy

  2016cites this paper
• Neuroprotection as a Therapeutic Target for Diabetic Retinopathy

  2016cites this paper